Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
China Renaissance Holdings ( (HK:1911) ) has issued an update.
China Renaissance Holdings Limited announced that its investee company, Shandong Weigao Blood Purification Products Co., Ltd., has successfully listed on the Shanghai Stock Exchange. Weigao Xuejing, a leader in China’s blood purification industry, has developed core technologies in hemodialysis and peritoneal dialysis, establishing a comprehensive supply chain for blood purification products. The listing underscores the confidence and investment capabilities of China Renaissance’s Huaxing Growth Capital Fund, which had previously led a significant investment in Weigao Xuejing.
More about China Renaissance Holdings
China Renaissance Holdings Limited operates in the financial services industry, focusing on investment management and advisory services. The company manages the Huaxing Growth Capital Fund, which invests in high-growth companies across various sectors.
YTD Price Performance: 7.34%
Average Trading Volume: 795,283
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.76B
Find detailed analytics on 1911 stock on TipRanks’ Stock Analysis page.